Brendan Harmon
Brendan Harmon, a doctoral candidate in the Department of Pharmaceutical Sciences, working in Professor Barbara Waszczak's laboratory was selected as one of the finalists at the Experimental Biology 2013 meeting. Brendan won third place, which includes a $250 prize and free registration for the 2014 meeting.
About Experimental Biology 2013:
Experimental Biology's mission is to share the newest scientific concepts and research findings shaping future and current clinical advances – and to give scientists and clinicians an unparalleled opportunity to hear from colleagues working on similar biomedical problems using different disciplines. With six sponsoring societies and another 20 U.S. and international guest societies, the annual meeting brings together scientists from throughout the United States and the world, representing dozens of scientific areas, from laboratory to translational to clinical research. The meeting also offers a wide spectrum of professional development sessions.
About the American Society for Pharmacology and Experimental Therapeutics:
ASPET is a 5,100 member scientific society whose members conduct basic and clinical pharmacological research within the academic, industrial and government sectors. Our members discover and develop new medicines and therapeutic agents that fight existing and emerging diseases, as well as increase our knowledge regarding how therapeutics affects humans.